JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds.
Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.
